Bivalirudin in Patients Undergoing PCI: State of Art and Future Perspectives.
Acute coronary syndrome (ACS) represents the most common cause of death worldwide. Percutaneous coronary intervention (PCI) is the management of choice in patients with ACS and occurrence of intra-procedural thrombotic complications are an independent predictor of mortality and other major adverse c...
| Main Authors: | , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Università di Salerno
2016
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912339/ |